Dark

ABBV
ABBVIE INC.
stock NYSE

At Close

Aug 7, 2026 3:59:59 PM EDT

245.85USD+0.804%(+1.96)4,699,892

230.37Bid 257.88Ask 27.51Spread

Pre-market

Aug 6, 2026 9:18:30 AM EDT

249.50USD+1.340%(+3.30)0

After-hours

Aug 7, 2026 4:10:30 PM EDT

246.04USD+0.077%(+0.19)886,452

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

434.52B

CEO

Richard Gonzalez

Headquarters

North Chicago, Illinois, USA

Industry

Drug Manufacturers-General

Last Dividend

Apr 15, 20251.640

AMGN NBIX GILD BIIB AZN GSK BMY LLY PFE XLV

ABBV Stats

Avg. Vol. 10 Day

6,127,110

Avg. Vol. 30 Day

7,956,793

Employees

30,000

Market Cap

434,516,469,209

Shares Out.

1,767,117,285

On/Off Exchange

51%/49%

6 Month Beta

-0.21

1 Year Beta

-0.08

2 Year Beta

0.27

3 Year Beta

0.27

52 Week Low

190.75

52 Week High

267.47

SMA50

240.54

SMA200

225.03

1 Week

-2.01%

1 Month

-3.44%

3 Month

+21.30%

6 Month

+10.05%

1 Year

+23.65%

2 Year

+31.13%

5 Year

+114.85%

Profile

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

ABBV Stock Summary

ABBVIE INC. (NYSE:ABBV) stock price today is $245.85, and today's volume is 4,699,892. ABBV is up 0.804% today. The 30 day average volume is 7,956,793. ABBV market cap is 434.52B with 1,767,117,285 shares outstanding.

document.getElementById("by576b").onerror = function(){this.style.display='none';}; .dark-mode .RvSc7d{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .RvSc7d{ color: #333333; background-color: white; border: 2px solid #333333; }ABBVABBVIE INC.stock NYSE

ABBV Stock Summary

ABBV
ABBVIE INC.
stock NYSE